Latest Carcinoma Stories

WOONSOCKET, R.I., Dec. 26, 2012 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) presented at the 2012 American Society for Cell Biology® (ASCB®) Annual Meeting in San Francisco, CA, on Tuesday, December 18. Simona Bot, M.D. presented preclinical research results in an abstract titled "Short Synthetic Double Stranded RNA with Dual Activity - Oncolytic and Immune Modulatory - for Hepatocellular Carcinoma." This research was supported by MultiCell via a...

A diagnosis of pancreatic cancer is particularly devastating since the prognosis for recovery is usually poor, with the cancer most often not detected until late stages. Research led by scientists at the University of California, San Diego and UC San Francisco Schools of Medicine examined the tumor-initiating events leading to pancreatic cancer (also called pancreatic ductal adenocarcinoma or PDA) in mice. Their work, published on line November 29 in the journal Cancer Cell, may help in...

A team of scientists, led by researchers at the University of California, San Diego School of Medicine, has shown for the first time how cancer cells control the ON/OFF switch of a program used by developing embryos to effectively metastasize in vivo, breaking free and spreading to other parts of the body, where they can proliferate and grow into secondary tumors. The findings are published in the December 11 issue of the journal Cancer Cell. In 90 percent of cancer deaths, it is the...

SAN DIEGO, Nov. 14, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors, announced positive interim results from a Phase IV trial investigating the use of NeoPulse in skin cancer patients at the 6th World Meeting of Interdisciplinary Melanoma/Skin Care Centres & 8th EADO Congress. Data from the trial showed a complete response of greater than 90 percent...

Those individuals who work outdoors with resultant sun exposure are at increased risk for non-melanoma skin cancers, such as squamous cell carcinoma and basal cell carcinoma. Manigé Fartasch shows that the connection between occupational UV exposure and squamous cell carcinoma is now well-established in her review article in issue 43 of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2012; 109(43): 715−20). The results are less clear for basal cell carcinoma, another form of...

COLORADO SPRINGS, Colo., Nov. 1, 2012 /PRNewswire/ -- Cannabis Science Inc., (CBIS) announced today the appointment of Christopher Meenan MS., MBA, as Executive Vice President of Product Research and Development, adding significant expertise to Cannabis Science's investigation of CS-TATI-1 for Karposi's Sarcoma and CS-S/BCC-1 for Basal and Squamous Cell Carcinomas, the Company's lead initiatives entering initial clinical development. Christopher Meenan joins Dr. Roscoe Moore,...

Alan McStravick for redOrbit.com - Your Universe Online In the 1970’s, as the general consciousness was being raised on the negative effects UV rays could have on skin, a fantastic solution arose. The advent of indoor tanning beds seemed the perfect way to maintain a golden hue without all the pesky side-effects that were coming to light, so to speak. People believed that indoor tanning minimized and even negated the negative health aspects of tanning in direct sunlight. Finally, a...

BOCA RATON, Fla., Sept. 28, 2012 /PRNewswire/ -- Sensus Healthcare is pleased to announce the acceptance and publication of the most comprehensive study to date on treating Non Melanoma Skin Cancer (NMSC) with superficial radiotherapy (SRT) in the Journal of the American Academy of Dermatology (JAAD). The comprehensive study, which examined 1,715 NMSC lesions in 1,149 patients, dubbed "Superficial x-ray in the treatment of basal and squamous cell carcinomas", was authored by...

BOCA RATON, Fla., Sept. 26, 2012 /PRNewswire/ -- Sensus Healthcare is proud to announce a major milestone in selling its 100th SRT-100(TM) advanced superficial radiotherapy (SRT) system. The SRT-100(TM) is a global success for treating Non Melanoma Skin Cancer on all major continents. The SRT-100(TM) provides patients with a virtually pain-free non-invasive treatment option, while achieving excellent outcomes that are comparable to surgery, and without scarring. Sensus Healthcare has...

European researchers image blood vessels that feed skin cancer with OCT for the first time The trained eye of a dermatologist can identify many types of skin lesions, but human sight only goes so far. Now an international team of researchers has developed an advanced optics system to noninvasively map out the network of tiny blood vessels beneath the outer layer of patients' skin, potentially revealing telltale signs of disease. Such high resolution 3-D images could one day help doctors...